These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1035 related items for PubMed ID: 24176881

  • 1. Characterization of the APP/PS1 mouse model of Alzheimer's disease in senescence accelerated background.
    Lok K, Zhao H, Shen H, Wang Z, Gao X, Zhao W, Yin M.
    Neurosci Lett; 2013 Dec 17; 557 Pt B():84-9. PubMed ID: 24176881
    [Abstract] [Full Text] [Related]

  • 2. Effects of accelerated senescence on learning and memory, locomotion and anxiety-like behavior in APP/PS1 mouse model of Alzheimer's disease.
    Lok K, Zhao H, Zhang C, He N, Shen H, Wang Z, Zhao W, Yin M.
    J Neurol Sci; 2013 Dec 15; 335(1-2):145-54. PubMed ID: 24095271
    [Abstract] [Full Text] [Related]

  • 3. Amyloid and tau pathology of familial Alzheimer's disease APP/PS1 mouse model in a senescence phenotype background (SAMP8).
    Porquet D, Andrés-Benito P, Griñán-Ferré C, Camins A, Ferrer I, Canudas AM, Del Valle J, Pallàs M.
    Age (Dordr); 2015 Feb 15; 37(1):9747. PubMed ID: 25663420
    [Abstract] [Full Text] [Related]

  • 4. Increase in presenilin 1 (PS1) levels in senescence-accelerated mice (SAMP8) may indirectly impair memory by affecting amyloid precursor protein (APP) processing.
    Kumar VB, Franko M, Banks WA, Kasinadhuni P, Farr SA, Vyas K, Choudhuri V, Morley JE.
    J Exp Biol; 2009 Feb 15; 212(Pt 4):494-8. PubMed ID: 19181896
    [Abstract] [Full Text] [Related]

  • 5. Urine formaldehyde level is inversely correlated to mini mental state examination scores in senile dementia.
    Tong Z, Zhang J, Luo W, Wang W, Li F, Li H, Luo H, Lu J, Zhou J, Wan Y, He R.
    Neurobiol Aging; 2011 Jan 15; 32(1):31-41. PubMed ID: 19879019
    [Abstract] [Full Text] [Related]

  • 6. Cholinergic degeneration is associated with increased plaque deposition and cognitive impairment in APPswe/PS1dE9 mice.
    Laursen B, Mørk A, Plath N, Kristiansen U, Bastlund JF.
    Behav Brain Res; 2013 Mar 01; 240():146-52. PubMed ID: 23178660
    [Abstract] [Full Text] [Related]

  • 7. Characterization of cognitive deficits in a transgenic mouse model of Alzheimer's disease and effects of donepezil and memantine.
    Nagakura A, Shitaka Y, Yarimizu J, Matsuoka N.
    Eur J Pharmacol; 2013 Mar 05; 703(1-3):53-61. PubMed ID: 23276665
    [Abstract] [Full Text] [Related]

  • 8. Neuroendocrine immunomodulation network dysfunction in SAMP8 mice and PrP-hAβPPswe/PS1ΔE9 mice: potential mechanism underlying cognitive impairment.
    Wang JH, Cheng XR, Zhang XR, Wang TX, Xu WJ, Li F, Liu F, Cheng JP, Bo XC, Wang SQ, Zhou WX, Zhang YX.
    Oncotarget; 2016 Apr 26; 7(17):22988-3005. PubMed ID: 27049828
    [Abstract] [Full Text] [Related]

  • 9. The behavioral, pathological and therapeutic features of the senescence-accelerated mouse prone 8 strain as an Alzheimer's disease animal model.
    Cheng XR, Zhou WX, Zhang YX.
    Ageing Res Rev; 2014 Jan 26; 13():13-37. PubMed ID: 24269312
    [Abstract] [Full Text] [Related]

  • 10. Regional metabolic alteration of Alzheimer's disease in mouse brain expressing mutant human APP-PS1 by 1H HR-MAS.
    Woo DC, Lee SH, Lee DW, Kim SY, Kim GY, Rhim HS, Choi CB, Kim HY, Lee CU, Choe BY.
    Behav Brain Res; 2010 Jul 29; 211(1):125-31. PubMed ID: 20307581
    [Abstract] [Full Text] [Related]

  • 11. The effect of focal brain injury on beta-amyloid plaque deposition, inflammation and synapses in the APP/PS1 mouse model of Alzheimer's disease.
    Collins JM, King AE, Woodhouse A, Kirkcaldie MT, Vickers JC.
    Exp Neurol; 2015 May 29; 267():219-29. PubMed ID: 25747037
    [Abstract] [Full Text] [Related]

  • 12. Deposition of mouse amyloid beta in human APP/PS1 double and single AD model transgenic mice.
    van Groen T, Kiliaan AJ, Kadish I.
    Neurobiol Dis; 2006 Sep 29; 23(3):653-62. PubMed ID: 16829076
    [Abstract] [Full Text] [Related]

  • 13. Pseudoginsenoside-F11 alleviates cognitive deficits and Alzheimer's disease-type pathologies in SAMP8 mice.
    Zhang Z, Yang J, Liu C, Xie J, Qiu S, Yang X, Wu C.
    Pharmacol Res; 2019 Jan 29; 139():512-523. PubMed ID: 30394318
    [Abstract] [Full Text] [Related]

  • 14. Age- and Brain Region-Specific Changes of Glucose Metabolic Disorder, Learning, and Memory Dysfunction in Early Alzheimer's Disease Assessed in APP/PS1 Transgenic Mice Using 18F-FDG-PET.
    Li XY, Men WW, Zhu H, Lei JF, Zuo FX, Wang ZJ, Zhu ZH, Bao XJ, Wang RZ.
    Int J Mol Sci; 2016 Oct 18; 17(10):. PubMed ID: 27763550
    [Abstract] [Full Text] [Related]

  • 15. Neuropathology of mice carrying mutant APP(swe) and/or PS1(M146L) transgenes: alterations in the p75(NTR) cholinergic basal forebrain septohippocampal pathway.
    Jaffar S, Counts SE, Ma SY, Dadko E, Gordon MN, Morgan D, Mufson EJ.
    Exp Neurol; 2001 Aug 18; 170(2):227-43. PubMed ID: 11476589
    [Abstract] [Full Text] [Related]

  • 16. The effect of ageing on neurogenesis and oxidative stress in the APP(swe)/PS1(deltaE9) mouse model of Alzheimer's disease.
    Hamilton A, Holscher C.
    Brain Res; 2012 Apr 17; 1449():83-93. PubMed ID: 22418058
    [Abstract] [Full Text] [Related]

  • 17. Liraglutide can reverse memory impairment, synaptic loss and reduce plaque load in aged APP/PS1 mice, a model of Alzheimer's disease.
    McClean PL, Hölscher C.
    Neuropharmacology; 2014 Jan 17; 76 Pt A():57-67. PubMed ID: 23973293
    [Abstract] [Full Text] [Related]

  • 18. [Generation of Tau/App/PS1 triple-transgenic mouse model and the study of its biological characteristics].
    Wang LL, Na X, Zhu XN, Chen RZ, Wang H, Wang XL.
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2012 Jul 17; 28(4):294-7. PubMed ID: 23156717
    [Abstract] [Full Text] [Related]

  • 19. Treadmill exercise enhances synaptic plasticity, but does not alter β-amyloid deposition in hippocampi of aged APP/PS1 transgenic mice.
    Zhao G, Liu HL, Zhang H, Tong XJ.
    Neuroscience; 2015 Jul 09; 298():357-66. PubMed ID: 25917310
    [Abstract] [Full Text] [Related]

  • 20. Sensorimotor gating and memory deficits in an APP/PS1 double transgenic mouse model of Alzheimer's disease.
    Wang H, He J, Zhang R, Zhu S, Wang J, Kong L, Tan Q, Li XM.
    Behav Brain Res; 2012 Jul 15; 233(1):237-43. PubMed ID: 22595040
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 52.